Trump Hints at Timeline for Tariffs on $1.6 Billion of Aussie Exports

Australian filmmaker turns to Chinese market to counter US tariffs

Many Australian film producers are looking to deepen ties with China as the world's film industry faces uncertainty following US President Donald Trump's proposed tariffs on all non-Hollywood productions.

Trump hints at timeline for tariffs on $1.6 billion of Aussie exports

US President Donald Trump has said he will "probably" impose tariffs on pharmaceutical drug imports from the end of July.

Op-Ed: Tariffs on allies' drugs would deliver a blow to U.S. industry

President Trump will soon announce new "Section 232" tariffs on pharmaceutical imports to bolster national security.

How Trump’s Trade Threats Impact ASX Sector Investments

As trade tensions flare under Donald Trump’s leadership, the global economic landscape is once again facing turmoil. This time, Trump’s rhetoric has brought forward threats of higher tariffs on various imports, including pharmaceutical products and copper. While these threats may seem distant to Australian investors, the potential impacts are significant and should not be underestimated.…

Pharmaceutical Industry Braces For Impact Of Tariffs

By Katherine Zehnder Carolina Journal RALEIGH – Surging pharmaceutical imports and front-loaded shipments driven by tariff fears are reshaping North Carolina’s trade landscape, as experts and analysts warn that escalating uncertainty in global trade policy is leaving businesses too anxious to plan ahead. Mike Hubbard, the director of international trade for the Economic Development Partnership […]

Do pharmaceutical tariffs threaten the PBS? - Nursing Review

US President Donald Trump’s proposed tariffs on Australia’s pharmaceutical exports to the United States has raised alarm among industry and government leaders. There are fears that, if implemented, the tariffs could cost the Australian economy up to A$2.8 billion. That’s both in direct exports and as inputs to third countries that produce drugs also hit by tariffs. The proposed tariffs come amid growing pressure from pharmaceutical lobby groups …